熱門資訊> 正文
PERI、ITRM和CADL在上市前的输家中
2024-04-08 20:23
- Losers: Perion Network Ltd. (PERI) -38% announces preliminary Q1 2024 financial results.
- 22nd Century Group (XXII) -37%.
- MediaCo Holding (MDIA) -29%.
- Bit Origin Ltd (BTOG) -17%.
- DatChat (DATS) -15%.
- ZOOZ Power Ltd. Ordinary Shares (ZOOZ) -14%.
- BioRestorative Therapies (BRTX) 5% with Galen Patient recruitment to accelerate completion of enrollment in Phase 2 trial of BRTX-100 in Chronic Lumbar Disc disease.
- Zhongchao (ZCMD) -11%.
- Adial Pharmaceuticals (ADIL) %.
- Globavend Holdings Limited (GVH) -9%.
- i-80 Gold Corp (IAUX) -10%.
- HWH International (HWH) -8%.
- Iterum Therapeutics Plc (ITRM) -9%.
- Allurion Technologies (ALUR) -8%.
- Nexalin Technology (NXL) -7%.
- Hub Cyber Security Ltd (HUBC) -7%.
- VivoPower International PLC (VVPR) -6%.
- Flora Growth Corp (FLGC) -5%.
- Candel Therapeutics (CADL) -5%.
- CCSC Technology International Holdings Ltd (CCTG) -6%.
More on pre-market losers & stocks.
- Perion Network: The Price Is Too Low To Ignore, Potentially Worth At Least Double
- Perion Network: Profitable Growth Company Trading At A Discount
- Iterum Therapeutics plc (ITRM) Q4 2023 Earnings Call Transcript
- Perion Network cuts annual core profit, revenue forecast, shares drop
- Candel stock soars on positive data from mid-stage pancreatic cancer drug trial
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。